Sirolimus in Liver Transplant Recipients: A Large Single-Center Experience
✍ Scribed by M. Vivarelli; A. Dazzi; A. Cucchetti; A. Gasbarrini; M. Zanello; P. Di Gioia; G. Bianchi; M.R. Tamè; M.D. Gaudio; M. Ravaioli; M. Cescon; G.L. Grazi; A.D. Pinna
- Book ID
- 116936260
- Publisher
- Elsevier Science
- Year
- 2010
- Tongue
- English
- Weight
- 205 KB
- Volume
- 42
- Category
- Article
- ISSN
- 0041-1345
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Few studies have reported a series of patients who have undergone portocaval hemitransposition at the time of orthotopic liver transplantation (OLT). Furthermore, no series report the outcome of pediatric patients who required the procedure. This work analyzes the experience with portocaval hemitran
The long-term use of calcineurin inhibitors (CIs) is associated with significant morbidity in liver transplant recipients. Although mycophenolate mofetil (MMF) is well tolerated, two small studies reported an unacceptable rate of acute allograft rejection in liver transplant recipients receiving MMF